Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.


The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page


My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1996 3
1997 2
1998 1
1999 4
2000 3
2001 6
2002 3
2003 1
2004 3
2005 2
2006 2
2007 4
2008 2
2009 5
2010 3
2011 6
2012 3
2013 5
2014 6
2015 4
2016 11
2017 6
2018 7
2019 6
2020 3
2021 4
2022 9
2023 7
2024 3

Text availability

Article attribute

Article type

Publication date

Search Results

115 results

Results by year

Filters applied: . Clear all
Page 1
Activation of the aryl hydrocarbon receptor improves allergen-specific immunotherapy of murine allergic airway inflammation: a novel adjuvant option?
Heine S, Alessandrini F, Grosch J, Graß C, Heldner A, Schnautz B, Grosch J, Buters J, Slusarenko BO, Krappmann D, Fallarino F, Ohnmacht C, Schmidt-Weber CB, Blank S. Heine S, et al. Among authors: krappmann d. Front Immunol. 2024 Jun 10;15:1397072. doi: 10.3389/fimmu.2024.1397072. eCollection 2024. Front Immunol. 2024. PMID: 38915403 Free PMC article.
MALT1 substrate cleavage: what is it good for?
Moud BN, Ober F, O'Neill TJ, Krappmann D. Moud BN, et al. Among authors: krappmann d. Front Immunol. 2024 May 28;15:1412347. doi: 10.3389/fimmu.2024.1412347. eCollection 2024. Front Immunol. 2024. PMID: 38863711 Free PMC article. Review.
Unrestrained cleavage of Roquin-1 by MALT1 induces spontaneous T cell activation and the development of autoimmunity.
Schmidt H, Raj T, O'Neill TJ, Muschaweckh A, Giesert F, Negraschus A, Hoefig KP, Behrens G, Esser L, Baumann C, Feederle R, Plaza-Sirvent C, Geerlof A, Gewies A, Isay SE, Ruland J, Schmitz I, Wurst W, Korn T, Krappmann D, Heissmeyer V. Schmidt H, et al. Among authors: krappmann d. Proc Natl Acad Sci U S A. 2023 Nov 28;120(48):e2309205120. doi: 10.1073/pnas.2309205120. Epub 2023 Nov 21. Proc Natl Acad Sci U S A. 2023. PMID: 37988467 Free PMC article.
Translational Studies Using the MALT1 Inhibitor (S)-Mepazine to Induce Treg Fragility and Potentiate Immune Checkpoint Therapy in Cancer.
Di Pilato M, Gao Y, Sun Y, Fu A, Grass C, Seeholzer T, Feederle R, Mazo I, Kazer SW, Litchfield K, von Andrian UH, Mempel TR, Jenkins RW, Krappmann D, Keller P. Di Pilato M, et al. Among authors: krappmann d. J Immunother Precis Oncol. 2023 Mar 3;6(2):61-73. doi: 10.36401/JIPO-22-18. eCollection 2023 May. J Immunother Precis Oncol. 2023. PMID: 37214210 Free PMC article.
Function and targeting of MALT1 paracaspase in cancer.
O'Neill TJ, Tofaute MJ, Krappmann D. O'Neill TJ, et al. Among authors: krappmann d. Cancer Treat Rev. 2023 Jun;117:102568. doi: 10.1016/j.ctrv.2023.102568. Epub 2023 Apr 26. Cancer Treat Rev. 2023. PMID: 37126937 Free article. Review.
Human TH17 cells engage gasdermin E pores to release IL-1α on NLRP3 inflammasome activation.
Chao YY, Puhach A, Frieser D, Arunkumar M, Lehner L, Seeholzer T, Garcia-Lopez A, van der Wal M, Fibi-Smetana S, Dietschmann A, Sommermann T, Ćiković T, Taher L, Gresnigt MS, Vastert SJ, van Wijk F, Panagiotou G, Krappmann D, Groß O, Zielinski CE. Chao YY, et al. Among authors: krappmann d. Nat Immunol. 2023 Feb;24(2):295-308. doi: 10.1038/s41590-022-01386-w. Epub 2023 Jan 5. Nat Immunol. 2023. PMID: 36604548 Free PMC article.
115 results